RxDoctor Payments DataLook up a doctor →

Warner Carr, MD

Allergy · Laguna Niguel, CANPI 1184798001

Payments from drug & device makers

$2,397,179in general payments, 2019–2025

Across 1,425 payments — averaging $1682.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$719K
  • AstraZeneca$326K
  • Aimmune Therapeutics, Inc.$242K
  • GSK$129K
  • Novartis$109K
  • Astrazeneca UK Limited$109K
  • plus $764K from 51 others
$5,781in research payments, 2019–2025

Across 11 payments — averaging $525.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi-aventis U.S. LLC$6K
  • Regeneron$234

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron160$718,777
AstraZeneca278$326,421
Aimmune Therapeutics, Inc.70$241,613
GSK81$128,772
Novartis44$108,853
Astrazeneca UK Limited9$108,569
Eli Lilly2$95,628
Teva Pharmaceuticals USA, Inc.37$95,244
AbbVie80$89,646
Regeneron Healthcare Solutions, Inc.87$70,698
Merz North America, Inc.46$69,384
Shionogi Inc15$43,601
Sun Pharmaceutical Industries Inc.8$42,337
Sanofi US Services Inc.12$37,338
Sanofi58$32,401
Sanofi-aventis U.S. LLC1$31,150
ARS Pharmaceuticals Operations, Inc.21$27,036
Pfizer53$25,363
Merck15$15,274
Dermavant Sciences, Inc.47$14,229
Blueprint Medicines Corporation17$10,431
Lilly USA, LLC8$9,632
Optinose US, Inc.27$9,495
Hikma Pharmaceuticals USA24$6,965
Merz Pharmaceuticals, LLC2$6,900
Amgen(2 entities)28$6,138
Incyte Corporation27$5,651
Alk-abello, Inc8$4,350
Aquestive Therapeutics, Inc.3$4,207
Genentech, Inc.4$2,306
Genentech USA, Inc.12$1,796
Janssen Global Services, LLC1$1,760
E.r. Squibb & Sons, L.L.C.1$1,095
Takeda Pharmaceuticals U.S.A., Inc.35$835
Eyevance Pharmaceuticals LLC1$600
Grifols USA, LLC12$363
Pharming Healthcare, Inc.15$351
CSL Behring15$351
Biocryst US Sales Co., LLC12$292
LEO Pharma Inc.9$275
Galderma Laboratories, L.p.12$254
Octapharma USA, Inc.4$149
Janssen Research & Development, LLC1$117
Kaleo, Inc.4$87
Boehringer Ingelheim3$74
Azurity Pharmaceuticals, Inc.2$64
GC Biopharma USA, Inc.2$40
Kyowa Kirin, Inc.1$37
ADMA Biomanufacturing LLC2$36
Jubilant Hollisterstier LLC1$30
Kedrion Biopharma, Inc.1$29
Oyster Point Pharma, Inc.1$25
Organon2$25
Cycle Pharmaceuticals Inc1$24
Greer Laboratories, Inc.1$23
Arcutis Biotherapeutics, Inc.1$23
Phadia US Inc.1$18

How this compares

$2,397,179 in reported general payments places this provider in the 95th percentile of 117 allergy providers in California.

See all allergy providers in California →

Medicare billing

Part B allowed, 2024
$156,012
Medicare patients
191
Services billed
5,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy in Laguna Niguel

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →